Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093750147> ?p ?o ?g. }
- W2093750147 endingPage "476" @default.
- W2093750147 startingPage "470" @default.
- W2093750147 abstract "To identify pathologic features that may account for the favorable survival after resection of invasive pancreatic adenocarcinoma arising in the setting of intraductal papillary mucinous neoplasm (IPMN) compared with standard pancreatic ductal adenocarcinoma (PDA) in the absence of IPMN.The 5-year survival after resection of IPMN-associated invasive adenocarcinoma is reported to be between 40% and 60%, which is superior to the 10-25%, typically cited after resection of standard PDA. It remains unclear whether this represents distinct biology or simply a tendency for earlier presentation of IPMN-associated invasive adenocarcinoma.A single institution's prospective pancreatic resection database was retrospectively reviewed to identify patients with invasive pancreatic adenocarcinoma who underwent pancreatectomy with curative intent. Log rank and Cox regression analysis were used to identify factors associated with survival.From 1995 to 2006, 1260 consecutive patients were identified, 132 (10%) with IPMN-associated invasive adenocarcinoma and 1128 (90%) with standard PDA. Actuarial 5-year survival was 42% after resection for IPMN-associated versus 19% for standard PDA (P < 0.001). However, compared with standard PDA, invasive adenocarcinoma arising within an IPMN was associated with a lower incidence of (1) advanced T stage (T2-T4, 96% vs. 73%, P < 0.001); (2) regional lymph node metastasis (78% vs. 51%, P < 0.001); (3) poor tumor differentiation (44% vs. 26%, P < 0.001); (4) vascular invasion (54% vs. 33%, P < 0.001); (5) perineural invasion (92% vs. 63%, P < 0.001); and (6) microscopic margin involvement (28% vs. 14%, P < 0.001). Specifically, in the presence of any one of the aforementioned adverse pathologic characteristics, outcomes after resection for IPMN-associated and standard PDA were not significantly different.The favorable biologic behavior of IPMN-associated compared with standard PDA is based on its lower rate of advanced T stage, lymph node metastasis, high tumor grade, positive resection margin, perineural, and vascular invasion. In the presence of any one of the aforementioned adverse pathologic characteristics, however, survival outcomes after resection of IPMN-associated and after resection of standard pancreatic adenocarcinoma are similar." @default.
- W2093750147 created "2016-06-24" @default.
- W2093750147 creator A5001682484 @default.
- W2093750147 creator A5021909013 @default.
- W2093750147 creator A5026919131 @default.
- W2093750147 creator A5043757838 @default.
- W2093750147 creator A5051619233 @default.
- W2093750147 creator A5055148537 @default.
- W2093750147 creator A5058146274 @default.
- W2093750147 creator A5065551581 @default.
- W2093750147 creator A5075915892 @default.
- W2093750147 creator A5083184392 @default.
- W2093750147 creator A5091546254 @default.
- W2093750147 date "2010-03-01" @default.
- W2093750147 modified "2023-10-05" @default.
- W2093750147 title "Histopathologic Basis for the Favorable Survival after Resection of Intraductal Papillary Mucinous Neoplasm-Associated Invasive Adenocarcinoma of the Pancreas" @default.
- W2093750147 cites W1964331135 @default.
- W2093750147 cites W1984676170 @default.
- W2093750147 cites W2010054000 @default.
- W2093750147 cites W2013102168 @default.
- W2093750147 cites W2020480128 @default.
- W2093750147 cites W2027249154 @default.
- W2093750147 cites W2031586352 @default.
- W2093750147 cites W2052862446 @default.
- W2093750147 cites W2095138156 @default.
- W2093750147 cites W2107827085 @default.
- W2093750147 cites W2118078989 @default.
- W2093750147 cites W2134226456 @default.
- W2093750147 cites W2146710224 @default.
- W2093750147 cites W2163301300 @default.
- W2093750147 doi "https://doi.org/10.1097/sla.0b013e3181cf8a19" @default.
- W2093750147 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3437748" @default.
- W2093750147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20142731" @default.
- W2093750147 hasPublicationYear "2010" @default.
- W2093750147 type Work @default.
- W2093750147 sameAs 2093750147 @default.
- W2093750147 citedByCount "202" @default.
- W2093750147 countsByYear W20937501472012 @default.
- W2093750147 countsByYear W20937501472013 @default.
- W2093750147 countsByYear W20937501472014 @default.
- W2093750147 countsByYear W20937501472015 @default.
- W2093750147 countsByYear W20937501472016 @default.
- W2093750147 countsByYear W20937501472017 @default.
- W2093750147 countsByYear W20937501472018 @default.
- W2093750147 countsByYear W20937501472019 @default.
- W2093750147 countsByYear W20937501472020 @default.
- W2093750147 countsByYear W20937501472021 @default.
- W2093750147 countsByYear W20937501472022 @default.
- W2093750147 countsByYear W20937501472023 @default.
- W2093750147 crossrefType "journal-article" @default.
- W2093750147 hasAuthorship W2093750147A5001682484 @default.
- W2093750147 hasAuthorship W2093750147A5021909013 @default.
- W2093750147 hasAuthorship W2093750147A5026919131 @default.
- W2093750147 hasAuthorship W2093750147A5043757838 @default.
- W2093750147 hasAuthorship W2093750147A5051619233 @default.
- W2093750147 hasAuthorship W2093750147A5055148537 @default.
- W2093750147 hasAuthorship W2093750147A5058146274 @default.
- W2093750147 hasAuthorship W2093750147A5065551581 @default.
- W2093750147 hasAuthorship W2093750147A5075915892 @default.
- W2093750147 hasAuthorship W2093750147A5083184392 @default.
- W2093750147 hasAuthorship W2093750147A5091546254 @default.
- W2093750147 hasBestOaLocation W20937501472 @default.
- W2093750147 hasConcept C121608353 @default.
- W2093750147 hasConcept C126322002 @default.
- W2093750147 hasConcept C141071460 @default.
- W2093750147 hasConcept C142724271 @default.
- W2093750147 hasConcept C159110652 @default.
- W2093750147 hasConcept C2776469228 @default.
- W2093750147 hasConcept C2777154038 @default.
- W2093750147 hasConcept C2778132481 @default.
- W2093750147 hasConcept C2778494859 @default.
- W2093750147 hasConcept C2778740770 @default.
- W2093750147 hasConcept C2778764654 @default.
- W2093750147 hasConcept C2779013556 @default.
- W2093750147 hasConcept C2780210213 @default.
- W2093750147 hasConcept C2781182431 @default.
- W2093750147 hasConcept C50382708 @default.
- W2093750147 hasConcept C71924100 @default.
- W2093750147 hasConcept C90924648 @default.
- W2093750147 hasConceptScore W2093750147C121608353 @default.
- W2093750147 hasConceptScore W2093750147C126322002 @default.
- W2093750147 hasConceptScore W2093750147C141071460 @default.
- W2093750147 hasConceptScore W2093750147C142724271 @default.
- W2093750147 hasConceptScore W2093750147C159110652 @default.
- W2093750147 hasConceptScore W2093750147C2776469228 @default.
- W2093750147 hasConceptScore W2093750147C2777154038 @default.
- W2093750147 hasConceptScore W2093750147C2778132481 @default.
- W2093750147 hasConceptScore W2093750147C2778494859 @default.
- W2093750147 hasConceptScore W2093750147C2778740770 @default.
- W2093750147 hasConceptScore W2093750147C2778764654 @default.
- W2093750147 hasConceptScore W2093750147C2779013556 @default.
- W2093750147 hasConceptScore W2093750147C2780210213 @default.
- W2093750147 hasConceptScore W2093750147C2781182431 @default.
- W2093750147 hasConceptScore W2093750147C50382708 @default.
- W2093750147 hasConceptScore W2093750147C71924100 @default.
- W2093750147 hasConceptScore W2093750147C90924648 @default.
- W2093750147 hasIssue "3" @default.
- W2093750147 hasLocation W20937501471 @default.